Sarepta Therapeutics, Inc. revenue breakdown overview

Sarepta Therapeutics, Inc. revenue for the last year amounted to 1.24 B USD, the most of which — 1.24 B USD — came from its highest performing source at the moment, RNA-targeted Therapeutics, Gene Therapy and Other Genetic Therapeutic Modalities, the year earlier bringing 933.01 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Sarepta Therapeutics, Inc. 1.24 B USD, and the year before that — 933.01 M USD.